CIK 0001752828 · <br>Emerging growth company
Celularity Inc
Sign in to watch- Ticker
- CELU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831702591
- Phone
- (908) 768-2170
- Business address
- 170 PARK AVE, FLORHAM PARK, NJ, 07932
- Former names
- GX Acquisition Corp.
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 18,422,124 shares at an average $0.16 ($2,984,294)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale 10% owner sold 15,371,697 shares
- 8-K Event Material agreement · Unregistered share sale · Executive or director change · Other events
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Material agreement · New debt or obligation
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 4 Grant or award Chief Medical Officer acquired 875,000 shares (grant or award)
- 4/A Shares withheld for taxes Director gave up 10,844 shares (to pay taxes)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 4 Grant or award Director acquired 199,921 shares (grant or award)
- 4 Grant or award Director acquired 199,921 shares (grant or award)
Page 11 of 29 · 563 filings